Search

Search Constraints

You searched for: Author/Creator Andersen, Scott W.

Search Results

12. FTS3‐01‐03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT. (1st July 2019)

13. Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease. Issue 1 (14th February 2021)

16. Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

19. P3‐285: Safety of solanezumab in the expedition‐ext study up to 2 years in a mild to moderate Alzheimer's disease population. (1st July 2015)

20. P4‐076: INCLUSION OF PATIENTS WITH ALZHEIMER'S DISEASE PATHOLOGY IN SOLANEZUMAB EXPEDITION 3 USING FLORBETAPIR PET IMAGING OR INNO‐BIA ALZBIO3 CSF Aβ1‐42. (1st July 2014)